Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2023
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 111
Usage 2023
Downloads: 3,331,819
Altmetric mentions: 1,885
Articles
Page 132 of 155
-
Citation: Arthritis Res Ther 2003 5(Suppl 3):171
-
Structural and functional changes in the brains of fibromyalgia subjects evaluated with single photon emission computed spectrometry and magnetic resonance imaging
Citation: Arthritis Res Ther 2003 5(Suppl 3):169 -
Pentosidine in serum and synovial fluid in patients with knee osteoarthritis and its potential role of prediction of osteoarthritis progression
Citation: Arthritis Res Ther 2003 5(Suppl 3):167 -
Expression of focal adhesion kinase, Akt/PKB, Elk-1 and p90RSK in rheumatoid arthritis tissues but not at sites of cartilage invasion
Citation: Arthritis Res Ther 2003 5(Suppl 3):165 -
Potentiality of mesenchymal stem cells with ex vivo gene therapy for osteochondral defect in arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):163 -
Apoptosis, loss of B-cell tolerance and lymphoid neogenesis in Sjögren's syndrome
Citation: Arthritis Res Ther 2003 5(Suppl 3):161 -
Identification of kinectin as a novel Behcet's disease-related autoantigen
Citation: Arthritis Res Ther 2003 5(Suppl 3):157 -
Transcriptional regulation of Synoviolin is important for the proliferation of rhumatoid synovial cells
Citation: Arthritis Res Ther 2003 5(Suppl 3):142 -
Floating anchorage-independent fibroblast-like cells mediate cartilage destruction independently from the hyperplastic synovial tissue
Citation: Arthritis Res Ther 2003 5(Suppl 3):140 -
Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):138 -
Soluble 4A11 antigen: a novel mediator of leukocyte-endothelial adhesion and monocyte recruitment in rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):136 -
Gene transfer of p21Cip1 exerts multiple molecular effects in the treatment of arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):134 -
Pathogenic roles of IL-6 and IL-6 blocking therapy on rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):132 -
TNF-alpha blockade by nonviral gene therapy in collagen-induced arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):130 -
Regulatory T cells in experimental arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):128 -
Repair of local bone erosions by combined treatment with parathyroid hormone, osteoprotegerin and anti-tumor necrosis factor in tumor necrosis factor-transgenic mice
Citation: Arthritis Res Ther 2003 5(Suppl 3):126 -
Changes in the synovial cell proteome induced by hypoxia
Citation: Arthritis Res Ther 2003 5(Suppl 3):124 -
Significance of fatigue in patients with rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):122 -
Dendritic cells present a tissue-specific autoantigen under steady state and autoimmune conditions in the draining lymph node
Citation: Arthritis Res Ther 2003 5(Suppl 3):103 -
Natural antibodies and antiphospholipid antibodies bind to injured tissues, activate complement and cause tissue damage
Citation: Arthritis Res Ther 2003 5(Suppl 3):101 -
Multiplex autoantibody profiling using 'synovial proteome' microarrays identifies citrulline-modified peptides as major targets of the autoimmune response in rheumatoid arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):99 -
Impact of altered peptide derived from collagen II on T-cell activation and collagen-induced arthritis
Citation: Arthritis Res Ther 2003 5(Suppl 3):98 -
Circulating anergic B cells in the periphery of active systemic lupus erythematosus patients: functional and phenotypic characterization
Citation: Arthritis Res Ther 2003 5(Suppl 3):96 -
Establishment of juvenile and tolerant immune systems in patients with autoimmune diseases treated with immunoablation and autologous stem cell therapy
Citation: Arthritis Res Ther 2003 5(Suppl 3):94 -
Human cartilage glycoprotein-39 directed T-cell responses in health and arthritic diseases
Citation: Arthritis Res Ther 2003 5(Suppl 3):92 -
Does sustained downregulation of the TCRzeta chain define the transition from antigen mode to inflammation mode in effector T lymphocytes?
Citation: Arthritis Res Ther 2003 5(Suppl 3):90 -
The Th2 cytokines IL-4 and IL-10 are internal controllers of human Th1-biased immunity in vivo
Citation: Arthritis Res Ther 2003 5(Suppl 3):88 -
Repertoire analysis of anergic B cells from patients with systemic lupus erythematosus
Citation: Arthritis Res Ther 2003 5(Suppl 3):86 -
Synergistic interactions of proinflammatory cytokines with oncostatin M: implications for joint destruction
Citation: Arthritis Res Ther 2003 5(Suppl 3):71 -
Role of lipoxins, antiflammins and serum amyloid A signaling via the common ALXR receptor in joint tissue inflammation
Citation: Arthritis Res Ther 2003 5(Suppl 3):69 -
Negative regulation of the hypoxia-inducible transcription factors by IPAS defines a novel anti-angiogenesis therapeutic strategy
Citation: Arthritis Res Ther 2003 5(Suppl 3):67 -
Prostaglandin E2is an enhancer for IL-1β-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts
Citation: Arthritis Res Ther 2003 5(Suppl 3):65 -
Altered phosphorylation of Syp may be responsible for abnormal insulin-like growth factor-1 signaling in human osteoarthritic osteoblasts
Citation: Arthritis Res Ther 2003 5(Suppl 3):63 -
Tissue-engineered cartilage using thermoresponsive gelatin as an in situ forming and moldable scaffold with chondrocytes: in vitro and in vivo performances
Citation: Arthritis Res Ther 2003 5(Suppl 3):61 -
Cell biology and functional genomics of osteoarthritic chondrocytes
Citation: Arthritis Res Ther 2003 5(Suppl 3):59 -
The role of IL-4 in the control of mechanical stress-induced inflammatory mediators by rat chondrocytes
Citation: Arthritis Res Ther 2003 5(Suppl 3):57 -
Evidence that rosiglitazone acts as an antidegradative agent on cartilage cells in vitro
Citation: Arthritis Res Ther 2003 5(Suppl 3):55 -
Overexpression and induction of heat shock protein 70 protect chondrocytes from cell death in vitro and in vivo
Citation: Arthritis Res Ther 2003 5(Suppl 3):53 -
IFN-β for the treatment of rheumatoid arthritis?
Citation: Arthritis Res Ther 2003 5(Suppl 3):34 -
Effect of the combination of the proinflammatory cytokines IL-1, tumor necrosis factor-α and IL-17
Citation: Arthritis Res Ther 2003 5(Suppl 3):32 -
Failure of receptor revision in the autoreactive B cells in patients with systemic lupus erythematosus
Citation: Arthritis Res Ther 2003 5(Suppl 3):30 -
Antiphospholipid antibodies and thrombosis: pathogenesis of antiphospholipid syndrome
Citation: Arthritis Res Ther 2003 5(Suppl 3):28 -
Origins of systemic lupus erythematosus: genes, environment, and host immune response
Citation: Arthritis Res Ther 2003 5(Suppl 3):26 -
Implication of Synoviolin in pathogenesis of arthropathy
Citation: Arthritis Res Ther 2003 5(Suppl 3):24 -
Cellular therapies in musculoskeletal diseases: synovial-derived mesenchymal stem cells
Citation: Arthritis Res Ther 2003 5(Suppl 3):22 -
Regulation of RANKL signaling in arthritic bone destruction
Citation: Arthritis Res Ther 2003 5(Suppl 3):20 -
Regulation of synovial cell function by adenovirus vector-mediated gene transduction
Citation: Arthritis Res Ther 2003 5(Suppl 3):18 -
The actions of BAFF in B-lymphocyte maturation and its effects on the development of autoimmune disease
Citation: Arthritis Res Ther 2003 5(Suppl 3):16 -
Characterization of signaling complexes at the T-cell antigen receptor
Citation: Arthritis Res Ther 2003 5(Suppl 3):14 -
DNA degradation during apoptotic cell death
Citation: Arthritis Res Ther 2003 5(Suppl 3):1